297 related articles for article (PubMed ID: 19635564)
1. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
6. Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells.
Matsui T; Nishino Y; Maeda S; Takeuchi M; Yamagishi S
Microvasc Res; 2011 May; 81(3):269-73. PubMed ID: 21236267
[TBL] [Abstract][Full Text] [Related]
7. Irbesartan inhibits albumin-elicited proximal tubular cell apoptosis and injury in vitro.
Matsui T; Yamagishi S; Ueda S; Fukami K; Okuda S
Protein Pept Lett; 2010 Jan; 17(1):74-7. PubMed ID: 20214630
[TBL] [Abstract][Full Text] [Related]
8. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Okuda S; Imaizumi T
Ophthalmic Res; 2008; 40(1):10-5. PubMed ID: 18025836
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan blocks advanced glycation end products-induced vcam-1 gene expression in mesangial cells by restoring Angiotensin-converting enzyme 2 level.
Ishibashi Y; Matsui T; Yamagishi S
Horm Metab Res; 2014 Jun; 46(6):379-83. PubMed ID: 24297485
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
15. [Effects of irbesartan on renal advanced glycation end products and their receptor in rats with early diabetic nephropathy].
Long HB; Niu HX; Li XY; Zhou WD; He JH; Zhong J; Wei LB
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2433-6, 2441. PubMed ID: 20034895
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
17. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
18. [The effect of valsartan on the expression of the receptor for advanced glycation end products in human glomerular mesangial cells].
Zhong LN; Huang GL; Feng M; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):338-42. PubMed ID: 22097731
[TBL] [Abstract][Full Text] [Related]
19. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
[TBL] [Abstract][Full Text] [Related]
20. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway.
Cheng YZ; Yang SL; Wang JY; Ye M; Zhuo XY; Wang LT; Chen H; Zhang H; Yang L
Life Sci; 2018 Jul; 205():184-192. PubMed ID: 29702126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
